Joyce Foust is Manager of Accounting at LENZ Therapeutics, where she oversees and maintains the general accounting functions as well as special accounting projects. She has over a decade of progressive experience in public and corporate accounting.

Prior to joining LENZ, Joyce was Senior Accountant at ViaCyte Inc., where she helped lead operational accounting through the eventual sale of the company to Vertex for $320 million. She has extensive experience with large private and public companies, including complex accounting and SOX controls testing.

We are excited to have her on board and look forward to her support as we prepare for product approval and commercialization.